Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01524276 · ClinicalTrials.gov registry record
Product Surveillance Registry
A clinical trial of Intracranial Aneurysm and Neurological Disorders, sponsored by Medtronic.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 20
- Study locations
NCT01524276: Recruiting study of Intracranial Aneurysm and Neurological Disorders, sponsored by Medtronic.
NCT01524276 is a study of Intracranial Aneurysm and Neurological Disorders that is actively recruiting participants, run by Medtronic. The registered enrollment target is 100,000 participants, above the 2,053-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (4771% higher). The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01524276, a study of Intracranial Aneurysm and Neurological Disorders, is actively recruiting participants, sponsored by Medtronic.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.
Conditions Studied
Study Locations (20)
California
- - Aliso Viejo
- - Chula Vista
- - Colton
- - La Jolla
- - Los Angeles
- - Napa
- - Redwood City
- - Salinas
- - San Diego
- - Stanford
- - Torrance
- - Ventura
Colorado
- - Aurora
- - Colorado Springs
- - Lakewood
Alabama
- - Birmingham
- - Huntsville
Arizona
- - Chandler
- - Phoenix
Arkansas
- - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2012-01 |
| Est. Completion | 2040-01 |
What NCT01524276 shows while recruiting
NCT01524276 is an observational study that tracks outcomes without assigning an intervention. Its 100,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,053-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (4771% higher).
The record links to 10 conditions, with Intracranial Aneurysm appearing as the primary indexed condition, and to 0 interventions.
NCT01524276 names 20 study sites across 5 states, led by California, Colorado, Alabama.
Frequently Asked Questions
What is clinical trial NCT01524276 about?
NCT01524276 is a clinical study titled "Product Surveillance Registry". The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by stre...
What is the current status of trial NCT01524276?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2012-01. Estimated completion is 2040-01.
What conditions does trial NCT01524276 study?
This clinical trial studies the following conditions: Intracranial Aneurysm, Neurological Disorders, Cardiovascular Disorders, Digestive Disorders, Mechanical Circulatory Support.
Who is sponsoring clinical trial NCT01524276?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01524276 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracranial Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01524276's enrollment target sits among peer trials
100,000 1st of 14 higher than 14 of 14 other Intracranial Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intracranial Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
RECRUITING
-
Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry
RECRUITING
-
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
RECRUITING
-
@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms
RECRUITING
-
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
RECRUITING · NA
-
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
- NCT04869111 · 100,000 participants · NA
The BrainHealth Project
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia